The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 187.50
Bid: 180.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 15.00 (8.333%)
Open: 190.00
High: 190.00
Low: 187.50
Prev. Close: 187.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 May 2018 15:38

RNS Number : 8690N
Synectics PLC
11 May 2018
 

 

11 May 2018

 

 

 

Synectics plc

(the 'Company')

Exercise of Options under Share Plan and subsequent Sale of Shares

PDMR shareholdings

 

Synectics (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, announces that on 9 May 2018 the following share options, which vested under the performance criteria of its Performance Share Plan ('PSP'), were exercised and either held or sold by Executive Directors and other Persons Discharging Managerial Responsibility ('PDMRs').

 

 

Number of shares

Name

Position

Status

PSP options exercised

Of which, subsequently held in own name

Of which, subsequently sold

Paul Webb*

Chief Executive, Synectics plc

Executive Director and PDMR

50,000

26,322

23,678

Mike Stilwell

Finance Director, Synectics plc

Executive Director and PDMR

25,000

-

25,000

David Aindow

Business Strategy Director, Synectic Systems Group Limited

PDMR

25,000

-

25,000

Darren Alder

Divisional Director, Oil & Gas, Synectic Systems Group Limited

PDMR

7,500

-

7,500

Stacey Anderson

Managing Director, SSS Management Services

PDMR

7,500

-

7,500

Jeff Fail

Organisational Development Director, Synectics plc

PDMR

30,000

-

30,000

 

*Paul Webb, Chief Executive, sold sufficient shares to cover the immediate tax liability on exercise of the options. The balance of 26,322 shares were transferred into his own name.

 

Following these transactions, their total interests in Synectics shares are now as follows:

 

Name

Position

Ordinary shares held

Interest in shares in share schemes

Resultanttotalinterest

% ofissuedshare capital

Paul Webb

Chief Executive, Synectics plc

36,322

251,325

287,647

1.62%

Mike Stilwell

Finance Director, Synectics plc

6,910

26,273

33,183

0.19%

David Aindow

Business Strategy Director, Synectic Systems Group Limited

-

13,000

13,000

0.07%

Darren Alder

Divisional Director, Oil & Gas, Synectic Systems Group Limited

-

15,000

15,000

0.08%

Stacey Anderson

Managing Director, SSS Management Services

-

16,000

16,000

0.09%

Jeff Fail

Organisational Development Director, Synectics plc

-

14,000

14,000

0.08%

 

 

 

Full details of the PSP are set out in the Company's Annual Report for the year ended 30 November 2017.

 

Commenting, Paul Webb, Chief Executive, said:

 

"I am very pleased that the Company's performance has led to the vesting in full of the share awards issued in March 2015.

 

"I have chosen to retain the maximum number of shares from my award after selling sufficient to cover the immediate tax liability. Other award holders have made their own individual choices."

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Jan Mitson, Deputy Company Secretary

www.synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths/Henry Willcocks

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEALSFFDKPEFF
Date   Source Headline
24th Apr 202410:00 amRNSResult of AGM
24th Apr 20247:00 amRNSAGM Statement
17th Apr 20247:00 amRNSContract win with a major UK utility provider
9th Apr 20247:00 amRNSBoard Appointment and Grant of Options
3rd Apr 20247:00 amRNSDirector/PDMR Dealings
26th Mar 20247:00 amRNSDirectors / PDMRs' Interests in Shares
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
27th Feb 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Results and Investor Presentation
30th Jan 20247:00 amRNSContract Awards
19th Dec 20233:00 pmRNSHolding(s) in Company
11th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSContract Win
15th Nov 20237:00 amRNSInvestor Site Visit
23rd Oct 20237:00 amRNSDirectorate Changes
16th Oct 20237:00 amRNSLatest Release of Synectics’ Synergy Software
11th Oct 20237:00 amRNSDirector/PDMR Dealings
28th Sep 20237:00 amRNSAdditional Contract with West Midlands Police
11th Jul 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSContract Award
3rd Jul 20237:00 amRNSInvestor Presentation re interim results
19th Jun 20237:00 amRNSTrading Update and Notification of Results
11th May 20237:00 amRNSDirector dealings
2nd May 20237:00 amRNSNew Gaming Project in Asia
27th Apr 202311:51 amRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement
13th Apr 20237:00 amRNSContract Award
4th Apr 20238:09 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSPosting of Accounts and Notice of AGM
14th Mar 20237:00 amRNSPDMRs' Interests in Shares
22nd Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
13th Feb 20237:00 amRNSNotice of Results
13th Dec 20227:00 amRNSTrading Update
1st Dec 20227:00 amRNSCompletion of sale of non-core Business
11th Nov 20227:00 amRNSSale of non-core Business
7th Nov 20227:00 amRNSDirectorate Change
24th Oct 20227:00 amRNSBoard Change and Update on Chairman Recruitment
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSDirector’s and PDMRs' Interests in Share Schemes
12th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:00 pmRNSInvestor Presentation
5th Jul 20227:00 amRNSDirectorate Change
22nd Jun 20227:00 amRNSProposed Board Change
14th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSDirectorate Change
12th May 20228:12 amRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSAmendment to Performance Share Plan
10th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.